BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 37350436)

  • 1. Slow Mohs micrographic surgery for nail apparatus melanoma in situ.
    Zhang S; Wang Y; Fang K; Jia Q; Zhang H; Qu T
    Int J Dermatol; 2023 Sep; 62(9):1170-1175. PubMed ID: 37350436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes of Mohs micrographic surgery for invasive melanoma of the trunk and proximal portion of the extremities.
    Burnett ME; Brodland DG; Zitelli JA
    J Am Acad Dermatol; 2021 Mar; 84(3):661-668. PubMed ID: 32763327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of Mohs micrographic surgery (MMS) for melanoma in situ (MIS) of the trunk and proximal extremities.
    Stigall LE; Brodland DG; Zitelli JA
    J Am Acad Dermatol; 2016 Nov; 75(5):1015-1021. PubMed ID: 27473456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mohs micrographic surgery: a cost analysis.
    Cook J; Zitelli JA
    J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):698-703. PubMed ID: 9810885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of nail apparatus melanoma with Mohs micrographic surgery.
    Brodland DG
    Dermatol Surg; 2001 Mar; 27(3):269-73. PubMed ID: 11277896
    [No Abstract]   [Full Text] [Related]  

  • 6. Mohs micrographic surgery for the treatment of primary cutaneous melanoma.
    Zitelli JA; Brown C; Hanusa BH
    J Am Acad Dermatol; 1997 Aug; 37(2 Pt 1):236-45. PubMed ID: 9270510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low recurrence rates for in situ and invasive melanomas using Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining: tissue processing methodology to optimize pathologic staging and margin assessment.
    Etzkorn JR; Sobanko JF; Elenitsas R; Newman JG; Goldbach H; Shin TM; Miller CJ
    J Am Acad Dermatol; 2015 May; 72(5):840-50. PubMed ID: 25774012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating melanoma in situ and lentigo maligna with Mohs micrographic surgery in Australia.
    Foxton GC; Elliott TG; Litterick KA
    Australas J Dermatol; 2019 Feb; 60(1):33-37. PubMed ID: 29932208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous head and neck melanoma treated with Mohs micrographic surgery.
    Bricca GM; Brodland DG; Ren D; Zitelli JA
    J Am Acad Dermatol; 2005 Jan; 52(1):92-100. PubMed ID: 15627086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mohs micrographic surgery for thin stage I malignant melanoma: rationale for a modern management strategy.
    Kaspar TA; Wagner RF
    Cutis; 1992 Nov; 50(5):350-1. PubMed ID: 1468255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Melanoma In Situ Treated With Mohs Micrographic Surgery Compared With Wide Local Excision.
    Nosrati A; Berliner JG; Goel S; McGuire J; Morhenn V; de Souza JR; Yeniay Y; Singh R; Lee K; Nakamura M; Wu RR; Griffin A; Grimes B; Linos E; Chren MM; Grekin R; Wei ML
    JAMA Dermatol; 2017 May; 153(5):436-441. PubMed ID: 28241261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local Recurrence Rates of Malignant Melanoma After Mohs Micrographic Surgery Are Lowest With 5- to 10-mm Initial Margins: A Systematic Review and Meta-Analysis.
    Campbell EH; Crum OM; Chelf CJ; Demer AM; Brewer JD
    Dermatol Surg; 2023 Feb; 49(2):119-123. PubMed ID: 36728060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nail Unit Melanoma In Situ Treated With Mohs Micrographic Surgery.
    Matsumoto A; Strickland N; Nijhawan RI; Srivastava D
    Dermatol Surg; 2021 Jan; 47(1):98-103. PubMed ID: 32796325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency and reliability of histologic subtype classification in invasive and in situ melanoma treated with Mohs micrographic surgery.
    Stull CM; Nugent ST; Raj LK; Sobanko JF; Shin TM; Etzkorn JR; Higgins HW; Giordano CN; McMurray SL; Walker JL; Miller CJ
    J Am Acad Dermatol; 2023 May; 88(5):1211-1214. PubMed ID: 36669593
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of cutaneous melanoma of the face by Mohs micrographic surgery.
    Bienert TN; Trotter MJ; Arlette JP
    J Cutan Med Surg; 2003; 7(1):25-30. PubMed ID: 12447624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mohs Micrographic Surgery Using MART-1 Immunostain in the Treatment of Invasive Melanoma and Melanoma In Situ.
    Valentín-Nogueras SM; Brodland DG; Zitelli JA; González-Sepúlveda L; Nazario CM
    Dermatol Surg; 2016 Jun; 42(6):733-44. PubMed ID: 27158886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mohs micrographic surgery in rare cutaneous tumors: a retrospective study at a Brazilian tertiary university hospital.
    Buffo TH; Stelini RF; Serrano JYM; Pontes LT; Magalhães RF; de Moraes AM
    An Bras Dermatol; 2023; 98(1):36-46. PubMed ID: 36369200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes for Invasive Melanomas Treated With Mohs Micrographic Surgery: A Retrospective Cohort Study.
    Degesys CA; Powell HB; Hsia LB; Merritt BG
    Dermatol Surg; 2019 Feb; 45(2):223-228. PubMed ID: 30199430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mohs Micrographic Surgery Is Equivalent to Nail Unit Excision or Amputation for Melanoma In Situ of the Nail Unit: A Systematic Review and Meta-Analysis.
    Le M; Gabrielli S; Zloty D
    Dermatol Surg; 2023 Aug; 49(8):755-758. PubMed ID: 37249515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence Rate for Melanoma Excised by Mohs Micrographic Surgery Without Immunostaining.
    Vieira C; Jennings T; Renzi MA; Lawrence N; Decker A
    Dermatol Surg; 2022 May; 48(5):492-497. PubMed ID: 35298442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.